{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:03:46Z","timestamp":1760853826829},"reference-count":22,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.3892\/ol.2015.3121","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T05:06:38Z","timestamp":1429160798000},"page":"2449-2454","source":"Crossref","is-referenced-by-count":1,"title":["Artesunate-enhanced apoptosis of human high-risk myelodysplastic cells induced by the DNA methyltransferase inhibitor decitabine"],"prefix":"10.3892","volume":"9","author":[{"given":"YING","family":"WANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FUXU","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHUPENG","family":"WEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUJIE","family":"GUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XUAN","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XUEJUN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LING","family":"PAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,4,16]]},"reference":[{"key":"key20180108103745_b1-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(09)70003-8","article-title":"Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study","volume":"10","author":"Fenaux","year":"2009","journal-title":"Lancet Oncol"},{"key":"key20180108103745_b2-ol-0-0-3121","first-page":"116","article-title":"Expression analysis of genes involved in epigenetic regulation and apoptosis in human malignant haematopoietic cell lines treated with 5-azacytidine","volume":"16","author":"Stankov","year":"2011","journal-title":"J BUON"},{"key":"key20180108103745_b3-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.seminoncol.2011.11.011","article-title":"p53-independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies","volume":"39","author":"Saunthararajah","year":"2012","journal-title":"Semin Oncol"},{"key":"key20180108103745_b4-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"e26906","DOI":"10.1371\/journal.pone.0026906","article-title":"Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome","volume":"6","author":"Lin","year":"2011","journal-title":"PLoS One"},{"key":"key20180108103745_b5-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/leu.2011.44","article-title":"Recurrent DNMT3A mutations in patients with myelodysplastic syndromes","volume":"25","author":"Walter","year":"2011","journal-title":"Leukemia"},{"key":"key20180108103745_b6-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc3343","article-title":"The role of mutations in epigenetic regulators in myeloid malignancies","volume":"12","author":"Shih","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"key20180108103745_b7-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/cncr.26327","article-title":"A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome","volume":"118","author":"Faderl","year":"2012","journal-title":"Cancer"},{"key":"key20180108103745_b8-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1158\/1078-0432.CCR-08-2788","article-title":"Epigenetic modifiers: basic understanding and clinical development","volume":"15","author":"Piekarz","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180108103745_b9-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jnci\/95.5.399","article-title":"Inhibition of DNA methylation and reactivation of silenced genes by zebularine","volume":"95","author":"Cheng","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"key20180108103745_b10-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1517\/13543784.2011.554822","article-title":"New nucleoside analogs for patients with hematological malignancies","volume":"20","author":"Robak","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"key20180108103745_b11-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/leu.2008.397","article-title":"The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells","volume":"23","author":"Flotho","year":"2009","journal-title":"Leukemia"},{"key":"key20180108103745_b12-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00277-010-1015-0","article-title":"Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group","volume":"89","author":"Gotze","year":"2010","journal-title":"Ann Hematol"},{"key":"key20180108103745_b13-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1158\/1078-0432.CCR-07-1320","article-title":"A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemia","volume":"14","author":"Klisovic","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180108103745_b14-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tips.2010.08.001","article-title":"Targeting DNA methylation for epigenetic therapy","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"key20180108103745_b15-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"e23372","DOI":"10.1371\/journal.pone.0023372","article-title":"Mechanisms of resistance to decitabine in the myelodysplastic syndrome","volume":"6","author":"Qin","year":"2011","journal-title":"PLoS One"},{"key":"key20180108103745_b16-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1371\/journal.pone.0000693","article-title":"Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells","volume":"2","author":"Efferth","year":"2007","journal-title":"PLoS One"},{"key":"key20180108103745_b17-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1074\/jbc.M110.144188","article-title":"The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials","volume":"286","author":"Mercer","year":"2011","journal-title":"J Biol Chem"},{"key":"key20180108103745_b18-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood-2009-12-255125","article-title":"Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes","volume":"116","author":"Kondo","year":"2010","journal-title":"Blood"},{"key":"key20180108103745_b19-ol-0-0-3121","first-page":"279","article-title":"Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-\u0138B and PI3K\/Akt signaling pathways","volume":"39","author":"Thanaketpaisarn","year":"2011","journal-title":"Int J Oncol"},{"key":"key20180108103745_b20-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0165-6147(83)90490-X","article-title":"Analysis of combined drug effects: a new look at a very old problem","volume":"4","author":"Chou","year":"1983","journal-title":"Trends Phamacol Sci"},{"key":"key20180108103745_b21-ol-0-0-3121","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s12185-010-0697-3","article-title":"Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells","volume":"92","author":"Chen","year":"2010","journal-title":"Int J Hematol"},{"key":"key20180108103745_b22-ol-0-0-3121","first-page":"1185","article-title":"Effect of interaction of magnetic nanoparticles of Fe3O4 and artesunate on apoptosis of K562 cells","volume":"6","author":"Wang","year":"2011","journal-title":"Int J Nanomedicine"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2015.3121\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T08:39:09Z","timestamp":1515400749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2015.3121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,16]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,4,16]]},"published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.3892\/ol.2015.3121"],"URL":"https:\/\/doi.org\/10.3892\/ol.2015.3121","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,16]]}}}